671 related articles for article (PubMed ID: 37854681)
1. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
Rezaee A; Ahmadpour S; Jafari A; Aghili S; Zadeh SST; Rajabi A; Raisi A; Hamblin MR; Mahjoubin-Tehran M; Derakhshan M
Front Oncol; 2023; 13():1215194. PubMed ID: 37854681
[TBL] [Abstract][Full Text] [Related]
2. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
Razavi ZS; Tajiknia V; Majidi S; Ghandali M; Mirzaei HR; Rahimian N; Hamblin MR; Mirzaei H
Crit Rev Oncol Hematol; 2021 Jan; 157():103192. PubMed ID: 33290823
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNAs in gynecologic cancer.
Solati A; Thvimi S; Khatami SH; Shabaninejad Z; Malekzadegan Y; Alizadeh M; Mousavi P; Taheri-Anganeh M; Razmjoue D; Bahmyari S; Ghasemnejad-Berenji H; Vafadar A; Soltani Fard E; Ghasemi H; Movahedpour A
Clin Chim Acta; 2023 Nov; 551():117618. PubMed ID: 38375624
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs related to angiogenesis in gynecological cancer.
Rahimian N; Razavi ZS; Aslanbeigi F; Mirkhabbaz AM; Piroozmand H; Shahrzad MK; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Jun; 161(3):896-912. PubMed ID: 33781555
[TBL] [Abstract][Full Text] [Related]
5. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers.
Hashemipour M; Boroumand H; Mollazadeh S; Tajiknia V; Nourollahzadeh Z; Rohani Borj M; Pourghadamyari H; Rahimian N; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Apr; 161(1):314-327. PubMed ID: 33581845
[TBL] [Abstract][Full Text] [Related]
6. Small Non-Coding-RNA in Gynecological Malignancies.
Dwivedi SKD; Rao G; Dey A; Mukherjee P; Wren JD; Bhattacharya R
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802524
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis-related non-coding RNAs and gastrointestinal cancer.
Razavi ZS; Asgarpour K; Mahjoubin-Tehran M; Rasouli S; Khan H; Shahrzad MK; Hamblin MR; Mirzaei H
Mol Ther Oncolytics; 2021 Jun; 21():220-241. PubMed ID: 34095461
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.
Mousavi SM; Derakhshan M; Baharloii F; Dashti F; Mirazimi SMA; Mahjoubin-Tehran M; Hosseindoost S; Goleij P; Rahimian N; Hamblin MR; Mirzaei H
Mol Ther Oncolytics; 2022 Mar; 24():262-287. PubMed ID: 35071748
[TBL] [Abstract][Full Text] [Related]
9. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
Chen M; Lei N; Tian W; Li Y; Chang L
Ther Adv Med Oncol; 2022; 14():17588359221118010. PubMed ID: 35983027
[TBL] [Abstract][Full Text] [Related]
10. Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers.
Xu C; Xu P; Zhang J; He S; Hua T; Huang A
Front Oncol; 2024; 14():1349474. PubMed ID: 38737906
[TBL] [Abstract][Full Text] [Related]
11. Circulating non-coding RNAs in recurrent and metastatic ovarian cancer.
Schwarzenbach H; Gahan PB
Cancer Drug Resist; 2019; 2(3):399-418. PubMed ID: 35582568
[TBL] [Abstract][Full Text] [Related]
12. Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
Sanya DRA; Onésime D
Hum Cell; 2023 Jul; 36(4):1343-1372. PubMed ID: 37209205
[TBL] [Abstract][Full Text] [Related]
13. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.
Kansara S; Singh A; Badal AK; Rani R; Baligar P; Garg M; Pandey AK
Semin Cancer Biol; 2023 Oct; 95():1-12. PubMed ID: 37364663
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
Front Genet; 2021; 12():693259. PubMed ID: 34512721
[TBL] [Abstract][Full Text] [Related]
15. A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs.
Tran AM; Chalbatani GM; Berland L; Cruz De Los Santos M; Raj P; Jalali SA; Gharagouzloo E; Ivan C; Dragomir MP; Calin GA
Front Cell Dev Biol; 2020; 8():50. PubMed ID: 32211400
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNA dysregulation in skin cancers.
Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers.
Lin X; Qiu J; Hua K
Biosci Trends; 2018 Sep; 12(4):342-353. PubMed ID: 30146551
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers.
Ye M; Wang J; Pan S; Zheng L; Wang ZW; Zhu X
Mol Ther Oncolytics; 2022 Mar; 24():101-113. PubMed ID: 35024437
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers.
Pan Y; Mao Y; Jin R; Jiang L
Oncol Lett; 2018 Jan; 15(1):31-40. PubMed ID: 29285185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
